StockGuide AI - assistant for market research

Analysts Evercore ISI add Humana (HUM) and NRG Energy (NRG) to their Best Core Ideas list, highlighting dividend potential

08/04/2026, 01:37 PM investing recommendation Analysts: analysts, Evercore ISI healthcare energy

Evercore ISI has updated its Best Core Ideas list, adding dividend-paying stocks Humana and NRG Energy, which are expected to perform well over the next year. This move highlights the firm's focus on stocks with strong fundamentals and potential for growth, particularly in the health insurance and utilities sectors.

Merck (MRK) Raises Revenue Outlook Amid Strong New Drug Sales but Lowers Profit Guidance Due to Acquisition Charges

08/04/2026, 04:37 AM business forecast healthcare

Merck's second-quarter performance exceeded revenue expectations, prompting an increase in its revenue outlook, but the company lowered its profit guidance due to significant charges from recent acquisitions.

Retail Giants Walmart, Costco, and Amazon Poised to Benefit from Growing GLP-1 Weight-Loss Drug Market

08/01/2026, 06:31 AM business growth retail healthcare

Retail giants like Walmart, Costco, and Amazon are capitalizing on the growing trend of direct-to-consumer GLP-1 weight-loss drugs, as employers increasingly drop coverage for these medications. This shift not only enhances their market share but also fosters long-term customer relationships beyond just the sale of prescriptions.

Novo Nordisk (NVO) Shares Drop 10% Following Failed Heart Drug Trial Results

07/31/2026, 05:37 AM business stock_drop healthcare

Novo Nordisk's shares dropped significantly after the company announced that its late-stage trial for the heart drug ziltivekimab failed to show a meaningful reduction in major adverse cardiovascular events compared to a placebo, raising concerns about its pipeline and market execution.

Analysts upgrade Qnity (QNITY) and Corning (GLW) to Buy amid AI stock rebound, while Johnson & Johnson (JNJ) lowers earnings guidance due to acquisition-related costs

07/30/2026, 12:36 PM business rating_growth Analysts: analysts ai healthcare

The Nasdaq Composite experienced a significant rebound, rising over 2.5% due to strong performances from chipmakers and AI-related stocks, while Johnson & Johnson's lowered earnings guidance is not expected to impact its underlying business negatively.

Hims & Hers Health (HIMS) Shares Drop 10% Following FTC Lawsuit Over Data and Billing Practices

07/29/2026, 11:36 AM business stock_drop healthcare

Hims & Hers Health's stock dropped significantly following a lawsuit from the FTC, which accuses the company of misleading consumers regarding privacy and billing practices. This legal challenge could have serious implications for the company's reputation and financial stability in the competitive telehealth market.

Analysts expect Novartis (NVS) to complete a bullish reversal with potential upside target near $176

07/29/2026, 11:36 AM investing forecast Analysts: analysts healthcare

Novartis is approaching a potential breakout point that could signal a bullish reversal, with analysts suggesting a target price of around $176 if the stock maintains its current momentum. This development is significant as it indicates a sustained uptrend following a lengthy consolidation period.

Topic: healthcare